Department of Psychiatry, National Defense Medical College, Saitama, Japan.
Department of Psychiatry, National Defense Medical College, Saitama, Japan.
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Dec 20;103:109978. doi: 10.1016/j.pnpbp.2020.109978. Epub 2020 May 25.
Although several recent studies have suggested that neuroinflammation plays a role in depression, both medication and neuroinflammatory preventive strategies have been poorly investigated. Recent studies have indicated that preconditioning with lipopolysaccharide (LPS) reduces the damage that occurs following ischemic stroke and brain trauma. However, to date, the effects of LPS preconditioning on psychiatric symptoms have not been reported. Thus, we assessed gene expression and behavioral changes affected by preconditioning with low-dose (LD) LPS in male mice with systemic inflammation induced by administration of high-dose (HD) LPS. mRNA expression analyses of cytokine-, glial-, and oxidative stress-associated genes revealed that majority of these genes responded to HD LPS. Differential gene expression in the presence and absence of LD LPS preconditioning, identified a subset of genes that may contribute to the mechanism of LPS preconditioning in the brain. Notably, LPS preconditioning attenuated an increase in expression of the astrocyte marker Gfap caused by systemic inflammation, suggesting that astrocytes have a key role in endotoxin tolerance in the brain induced by LPS preconditioning. As increased astrocyte in the brain of patients with depression is suggested to contribute to the pathophysiology of major depression, LPS preconditioning might be applicable to the prevention and treatment of depression. Unfortunately, in this study, LPS preconditioning did not show a reversal effect on behavior decline due to high-dose LPS-induced systemic inflammation. Alternative aspects of behavioral changes should be assessed to identify behavioral components that are affected by LPS preconditioning. Nonetheless, the findings in the present study indicate the possibility of the mechanism of endotoxin tolerance induction in the brain via astrocyte regulation by LPS preconditioning. Since there has been reported pharmacological significance of astrocytes in psychiatric disorders, regulation of endotoxin tolerance might be a key method to control psychiatric symptoms.
尽管最近有几项研究表明神经炎症在抑郁症中起作用,但药物治疗和神经炎症预防策略的研究都很少。最近的研究表明,用脂多糖 (LPS) 预处理可减轻缺血性中风和脑外伤后的损伤。然而,迄今为止,尚未报道 LPS 预处理对精神症状的影响。因此,我们评估了低剂量 (LD) LPS 预处理对全身炎症模型中小鼠的基因表达和行为变化的影响,该模型通过给予高剂量 (HD) LPS 来诱导。细胞因子、神经胶质细胞和氧化应激相关基因的 mRNA 表达分析表明,大多数基因对 HD LPS 有反应。在存在和不存在 LD LPS 预处理的情况下的差异基因表达,确定了一组可能有助于 LPS 预处理在大脑中机制的基因。值得注意的是,LPS 预处理减轻了全身炎症引起的星形胶质细胞标志物 Gfap 表达的增加,表明星形胶质细胞在 LPS 预处理诱导的脑内内毒素耐受中起关键作用。由于抑郁症患者大脑中星形胶质细胞的增加被认为有助于重度抑郁症的病理生理学,因此 LPS 预处理可能适用于抑郁症的预防和治疗。不幸的是,在这项研究中,LPS 预处理并没有显示出对因高剂量 LPS 引起的全身炎症而导致的行为下降的逆转作用。应该评估行为变化的其他方面,以确定受 LPS 预处理影响的行为成分。尽管如此,本研究的结果表明,通过 LPS 预处理调节星形胶质细胞,在大脑中诱导内毒素耐受的可能性。由于已有报道称星形胶质细胞在精神疾病中有药理学意义,因此调节内毒素耐受可能是控制精神症状的关键方法。